Proton pump inhibitor therapy does not affect hydrogen production on lactulose breath test in subjects with IBS. (Q43260317)

17 November 2017

Proton pump inhibitor therapy does not affect hydrogen production on lactulose breath test in subjects with IBS. (English)

1 reference

17 November 2017

1 reference

1 reference

2

Mark Pimentel

1 reference

17 November 2017

David Law

1

1 reference

17 November 2017

16 October 2009

1 reference

Digestive Diseases and Sciences

17 November 2017

1 reference

17 November 2017

55

1 reference

17 November 2017

8

1 reference

17 November 2017

2302-2308

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-009-1010-2

17 November 2017

0 references

cites work

The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10620-009-1010-2

Omeprazole as a risk factor for campylobacter gastroenteritis: case-control study

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10620-009-1010-2

Studying the overlap between IBS and GERD: a systematic review of the literature

21 January 2018

1 reference

12 December 2020

Methane production during lactulose breath test is associated with gastrointestinal disease presentation

1 reference

12 December 2020

Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity

1 reference

12 December 2020

Somatic comorbidities of irritable bowel syndrome: a systematic analysis

1 reference

12 December 2020

The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an asian urban community

1 reference

12 December 2020

Duodenal bacterial overgrowth during treatment in outpatients with omeprazole

1 reference

12 December 2020

Bacterial overgrowth and irritable bowel syndrome: unifying hypothesis or a spurious consequence of proton pump inhibitors?

1 reference

12 December 2020

Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies

1 reference

12 December 2020

Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study

1 reference

12 December 2020

Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea

1 reference

12 December 2020

Prevalence of irritable bowel syndrome (IBS) and variability of diagnostic criteria.

1 reference

12 December 2020

Impact of irritable bowel syndrome: prevalence and effect on health-related quality of life.

1 reference

12 December 2020

Prevalence of irritable bowel syndrome: a community survey

1 reference

12 December 2020

The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects.

1 reference

12 December 2020

Small intestinal bacterial overgrowth in patients with irritable bowel syndrome

1 reference

12 December 2020

Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome

1 reference

12 December 2020

Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time

1 reference

12 December 2020

A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence

1 reference

12 December 2020

Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids

1 reference

12 December 2020

Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome.

1 reference

12 December 2020

Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease--where next?

1 reference

12 December 2020

Drug-induced hypochlorhydria causes high duodenal bacterial counts in the elderly

1 reference

12 December 2020

Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole

1 reference

12 December 2020

Antibacterial activity of the pancreatic fluid.

1 reference

12 December 2020

Small intestinal bacterial overgrowth in irritable bowel syndrome: association with colon motility, bowel symptoms, and psychological distress

1 reference

12 December 2020

Review article: proton pump inhibitors and bacterial overgrowth

1 reference

12 December 2020

A systematic review of diagnostic tests for small intestinal bacterial overgrowth

1 reference

12 December 2020

Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study

1 reference

12 December 2020

Overlap of gastrointestinal symptom complexes in a US community

1 reference

12 December 2020

10.1007/S10620-009-1010-2

Identifiers

DOI

1 reference

17 November 2017

1 reference

PubMed ID

19834807